Wednesday, May 3, 2017

WHO,Post Introduction Evaluation (PIE)Jobs in Rwanda



WHO REPRESENTATIVE OFFICE FOR RWANDA
Tel.: (+250) 280 300 507, Mobile (+250) 78 830 78 70
E-mail: afwcorw@who.int
P.O. Box 1324, Kigali, Rwanda
VACANCY ANNOUNCEMENT
Position Title:                         SSA/ Post Introduction Evaluation (PIE)
Type of Appointment:          Special Service Agreement (SSA)
Duration of contract:            2 months

Grade:                                    NOC
Duty Station:                         WHO/Kigali
Background and Justification
Rwanda is working towards various goals including measles elimination. These initiatives rely on the provision of vaccination services in routine immunization, in supplementary immunization activities and outbreak response campaigns, as well as the efforts put in conducting intensive diseases surveillance to monitor the progress and determine the impact of interventions.
The coverage of children fully immunized is 94% and the basic vaccination coverage among children aged 12-23 months has considerably increased, from 75% in 2005 to 93% in 2015. Rwanda has experienced MCV1 coverage of 86 %( DHS 2005), 86(DHS2007-2008), 95(DHS2010) and currently MCV1 is 99% and MR second dose is at 90% in 2016.
Rwanda has introduced Measles and rubella in 2013 followed by post MR campaign survey and obtained coverage of 98% and was integrated in routine immunization in 2014 and WHO recommends that all countries which have introduced a new vaccine conduct a PIE after its introduction and in Rwanda there was no PIE conducted after introducing Measles and Rubella second dose. According to the WHO guideline Rwanda is planning to conduct Post Introduction Evaluation of Measles and rubella second dose for evaluating the programmatic implication of the MR after its introduction in country. MR Post Introduction Evaluation will evaluate overall impact on country with focusing on a range of programmatic, such as pre-introduction planning, vaccine storage and wastage, logistics of administering and community receptiveness and will identify problem areas needing correction within immunization program either pre-existing or resulting from MR introduction and provide valuable lessons for future vaccine introductions.
Job Dimension
WHO is planning to support Rwanda Expanded Program on Immunization to conduct MR second dose Post Introduction Evaluation by providing Consultant for being able to evaluate overall impact on country with focusing on a range of programmatic, such as pre-introduction planning, vaccine storage and wastage, logistics of administering and community receptiveness and will identify problem areas needing correction within immunization program either pre‑ existing or resulting from MR introduction and provide valuable lessons for future vaccine introductions.
Tasks and Responsibilities
Under the guidance and supervision of the WHO/EPI Program Officer, the SSA will:
  • Facilitate the adaptation of the data collection tools in line with specific context of Rwanda so that the teams have the final questionnaires and other tools before leaving for the field and provide guidance for analysis of data collected during the evaluation;
  • Conduct a desk review of available documentation for the administration of 2nd dose of measles ensuring that key information is captured in the final PIE report;
  • Interview key MOH officials and key partners at national level;
  • Work with co-lead the national team conducting the evaluation in the selected provinces and districts health facilities to provide the findings of the evaluation;
  • Participate in debriefing of ICC and senior level government officials on the finding and recommendations of the evaluation;
  • Participate in the preparation of the preliminary report on the findings and recommendations of the evaluation;
  • Provide recommendations for rectifying typical problems associated with the Introduction of a MR second dose;
  • Submit the final report of the PIE, incorporating the comments from the debriefing of the ICC and other sources, and including the Plan of Action for the follow up on the recommendations;
  • Perform any other activities required by the WR.
    Required Profile
Education:
Essential: Medical degree with Master degree in Epidemiology or Public Health.
Desirable: (i) Master Degree in Public Health or Health planning, who previously conducted Immunization survey or PIE.
Experience:
Essential: 5 years of professional experience in the health sector with at least 3 years in conducting Post Introduction Survey Evaluation.
Desirable: (i) Experience in capacity building, planning and monitoring and evaluation of health programs; (ii) Experience working at operational as well as policy levels of the health system. (iii) Experience working with UN agencies or other international organizations
Languages:
Excellent knowledge of English, French and Kinyarwanda is required.
Functional skills & Competencies:
- Technical expertise in public health and epidemiology, planning and conducting survey especially on Immunization survey and Vaccine Post Introduction Evaluation with ability to work effectively with colleagues.
-     Familiarity with key health sector especially on Immunization interventions.
-     Familiarity with WHO procedures and practices is also required.
-     Ability to work under pressure;
- Excellent oral and written communication (report writing), computer and data analysis skills with ability to use Epi Info, STATA, Excel, PowerPoint and MS Word programs.
How to apply:
Written application accompanied by a detailed CV including three referees should be sent by e-mail to afwcorw@who.int, not later than 9 May 2017 before 5:00 pm.
Enclose:
-     Motivation Letter,
-     Detailed CV,
-     Copies of Education qualification,
-     Copy of ID card.
Kindly note that only short-listed candidates will be contacted.
Applications without all the above requirements will not be considered.
All application materials will not be returned.
This application is open only to Rwandan Nationals.
The deadline for application is 9 May 2017 before 5:00 pm
Dr Olushayo OLU
WHO Representative/Rwanda

No comments:

Post a Comment

ShareThis